Biodexa Pharmaceuticals Balance Sheet
Biodexa Pharmaceuticals's total assets for Q4 2025 were £18.15M, an increase of 22.42% from the previous quarter. BDRX total liabilities were £6.76M for the fiscal quarter, a 99.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.